Familial Nasopharyngeal Carcinoma 6

240 I. W. K. Tham and J. J. LuGan YY, Fones-Tan A, Chan SH (1996) Molecular diagnosis ofnasopharyngeal carcinoma: a review. Ann Acad MedSingapore 25(1):71–74Gong QY Zheng GL Zhu HY (1991) MRI differentiation ofrecurrent nasopharyngeal carcinoma from postradiationfibrosis. Comput Med Imaging Graph 15:423–429Koga DH, Salvajoli JV, Alves FA (2008) Dental extractions andradiotherapy in head and neck oncology: review of the literature.Oral Dis 14(1):40–44Kwong DL, Nicholls J, Wei WI, et al (1999) The time course ofhistologic remission after treatment of patients withnasopharyngeal carcinoma. Cancer 85(7):1446–1453Kwong DL, Nicholls J, Wei WI, et al (2001) Correlation of endoscopicand histologic findings before and after treatmentfor nasopharyngeal carcinoma. Head Neck 23(1):34–41Kwong DL, Sham JS, Au GK, et al (2004) Concurrent and adjuvantchemotherapy for nasopharyngeal carcinoma: a factorialstudy. J Clin Oncol 22(13):2643–2653Lam K, Tse V, Wang C, et al (1991) Effects of cranial irradiationon hypothalamic-pituitary function: a 5-year longitudinalstudy in patients with nasopharyngeal carcinoma. Q J Med78:165–176Langendijk JA, Doornaert P, Rietveld DH, et al (2009) A predictivemodel for swallowing dysfunction after curativeradiother apy in head and neck cancer. Radiother Oncol 90(2):189–195Lee AW, Foo W, Law SC, et al (1999) Recurrent nasopharyngealcarcinoma: the puzzles of long latency. Int J Radiat OncolBiol Phys 44(1):149–156Lee AW, Law SC, Foo W, et al (1993) Retrospective analysis ofpatients with nasopharyngeal carcinoma treated during1976–1985: survival after local recurrence. Int J RadiatOncol Biol Phys 26(5):773–782Lee N, Kong L (2008)Nasopharyngeal cancer. In: Lu JJ, BradyLW (eds) Radiation oncology: an evidence-based approach.Springer, BerlinLee N, Xia P, Quivey JM, et al (2002) Intensity-modulatedradiotherapy in the treatment of nasopharyngeal carcinoma:an update of the UCSF experience. Int J Radiat OncolBiol Phys 53(1):12–22Lee PW, Kwan TT, Kwong DL, et al (2007) A prospective studyof the impact of nasopharyngeal cancer and radiotherapyon the psychosocial condition of Chinese patients. Cancer109(7):1344–1354Lin JC, Wang WY, Chen KY, et al (2004) Quantification of plasmaEpstein–Barr virus DNA in patients with advanced nasopharyngealcarcinoma. N Engl J Med 350(24): 2461–2470Lin S, Pan J, Lu H, et al (2009) Nasopharyngeal carcinomatreated with reduced-volume intensity-modulated radiationtherapy: report on the 3-year outcome of a prospectiveseries. Int J Radiat Oncol Biol Phys , article in press, publishedonline 13 Apr 09Liu T, Xu W, Yan WL, et al (2007) FDG-PET, CT, MRI for diagnosisof local residual or recurrent nasopharyngeal carcinoma,which one is the best? A systematic review. RadiotherOncol 85(3):327–335Lo Galbo AM, de Bree R, Lips P, et al (2009) Detecting hypothyroidismafter treatment for laryngeal or hypopharyngealcarcinomas: a nationwide survey in The Netherlands. EurArch Otorhinolaryngol 266(5):713–718Loong HH, Ma BB, Chan AT (2008) Update on the managementand therapeutic monitoring of advanced nasopharyngealcancer. Hematol Oncol Clin North Am 22(6): 1267–1278Low WK, Toh ST, Wee J, et al (2006) Sensorineural hearing lossafter radiotherapy and chemoradiotherapy: a single,blinded, randomized study. J Clin Oncol 24(12): 1904–1909Ma LC (1996) Psychosocial stresses and adjustment ofnasopharyngeal carcinoma patients in Hong Kong: a panelstudy. Cancer Pract 4(5):258–266Ma X, Lu JJ, Loh KS, et al (2006) Role of computed tomographyimaging in predicting response of nasopharyngeal carcinomato definitive radiation therapy. Laryngoscope116(12):2162–2165Mercado G, Adelstein DJ, Saxton JP, et al (2001) Hypothyroidism:a frequent event after radiotherapy and after radiotherapywith chemotherapy for patients with head and neck carcinoma.Cancer 92:2892–2897National Comprehensive Cancer Center Clinical PracticeGuidelines (2009) http://www.nccn.org/professionals/physician_gls/PDF/head-and-neck.pdf.Accessed 23 Feb 2009Ng SH, Chang TC, Ko SF, et al (1999) MRI in recurrent nasopharyngealcarcinoma. Neuroradiology 41:862–885Ng SH, Joseph CT, Chan SC, et al (2004) Clinical usefulness of18F-FDG PET in nasopharyngeal carcinoma patients withquestionable MRI findings for recurrence. J Nucl Med45(10):1669–1676Ng SH, Liu HM, Ko SF, et al (2002) Posttreatment imaging ofthe nasopharynx. Eur J Radiol 44(2):82–95Ng SH, Wan YL, Ko SF, et al (1998) MRI of nasopharyngeal carcinomawith emphasis on relationship to radiotherapy. JMagn Reson Imaging 8:327–336Ragab SM, Erfan FA, Khalifa MA, et al (2008) Detection of localfailures after management of nasopharyngeal carcinoma: aprospective, controlled trial. J Laryngol Otol 122(11):1230–1234Sham JS, Wei WI, Kwan WH, et al (1990) Nasopharyngeal carcinoma.Pattern of tumor regression after radiotherapy.Cancer 65(2):216–220Shao JY, Li YH, Gao HY, et al (2004) Comparison of plasmaEpstein–Barr virus (EBV) DNA levels and serum EBV immunoglobulinA/virus capsid antigen antibody titers in patientswith nasopharyngeal carcinoma. Cancer 100(6): 1162–1170Sklar CA, Constine LS (1995) Chronic neuroendocrinologicalsequelae of radiation therapy. Int J Radiat Oncol Biol Phys31(5):1113–1121Tan BC, Kunaratnam M (1966) Hypopituitary dwarfism followingradiotherapy for nasopharyngeal carcinoma. ClinRadiol 17:302–304Wee J, Tan EH, Tai BC, et al (2005) Randomized trial of radiotherapyversus concurrent chemoradiotherapy followed byadjuvant chemotherapy in patients with American JointCommittee on Cancer/International Union against cancerstage III and IV nasopharyngeal cancer of the endemicvariety. J Clin Oncol 23(27):6730–6738Yen RF, Hong RL, Tzen KY, et al (2005) Whole-body 18F-FDGPET in recurrent or metastatic nasopharyngeal carcinoma.J Nucl Med 46(5):770–774Yen RF, Yen MF, Hong RL, et al (2009) The cost-utility analysisof 18-fluoro-2-deoxyglucose positron emission tomographyin the diagnosis of recurrent nasopharyngeal carcinoma.Acad Radiol 16(1):54–60Yen TC, Lin CY, Wang HM, et al (2006) 18F-FDG-PET for evaluationof the response to concurrent chemoradiation therapywith intensity-modulated radiation technique for stageT4 nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys65(5):1307–1314